wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37923861-150A3743-DAA1-4891-A6D9-29E3BD53CFC4
Q37923861-150A3743-DAA1-4891-A6D9-29E3BD53CFC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37923861-150A3743-DAA1-4891-A6D9-29E3BD53CFC4
The CDK inhibitors in cancer research and therapy.
P2860
Q37923861-150A3743-DAA1-4891-A6D9-29E3BD53CFC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37923861-150A3743-DAA1-4891-A6D9-29E3BD53CFC4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
125cf9170c97dfd4a71e91d16ddb92f18c9b88a4
P2860
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors.